Ian Sample, science
correspondent
Monday June 2, 2003
The Guardian
Researchers in Canada are testing a prototype vaccine which could
halt the spread of brain-wasting diseases such as scrapie, BSE and
its human form, Creutzfeldt-Jakob disease.
If the tests are successful, the vaccine will first be used to
wipe out the devastating infections, caused by rogue proteins called
prions, in national herds of cattle and sheep.
Prions occur naturally in all mammals and usually cause no
ill-effects. But sometimes, the proteins fold into abnormal shapes.
These can then spread around the body and convert other normal
prions into abnormal, disease-causing prions on contact.
A team led by Neil Cashman at the University of Toronto has now
found what could be the achilles heel of infectious prions. The team
took normal prions and forced them to fold into abnormal shapes in a
petri dish. They found that the prions exposed sections of protein
that were usually tucked inside normal proteins, remaining hidden.
Dr Cashman realised that the section of protein that was exposed
in abnormal prions, a short strand of three amino acids, was their
weakness.
To target the abnormal prions, he cut the three amino acids out
of the prions and tagged them to a molecule known to cause an immune
response in animals. He then injected them into mice. As Dr Cashman
hoped, the mice began to churn out antibodies against the amino
acids. Antibodies let the immune system identify anything in the
blood that should be destroyed.
The team then purified the antibodies from the mice and tested
them to see if they could identify infectious prions from other
animals.
"The amazing thing is that once we found it worked for hamster
scrapie and mouse scrapie, we tested all the samples we could lay
our hands on, from vCJD in humans, to BSE in cattle and scrapie in
sheep. It worked for every species," he said.
Dr Cashman, whose study was published yesterday in the journal
Nature Medicine, is now testing a vaccine which targets abnormal
prions in mice. If it works, the team will move on to sheep and
cattle.
The vaccine may be of little use for humans, however. "You
wouldn't want to vaccinate every person against a disease that only
affects about one in a million," he said. But the discovery could
lead to a new therapy for CJD, triggering the immune system to mop
up rogue prions in the brain.